Serum Homocysteine, Vitamin B12 and Folic Acid Levels in Patients with Metabolic Syndrome.
暂无分享,去创建一个
[1] A. Marti-Carvajal,et al. Homocysteine-lowering interventions for preventing cardiovascular events. , 2017, The Cochrane database of systematic reviews.
[2] A. Chandra,et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease , 2013, Neurology.
[3] Taner Uçgun,et al. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study. , 2013, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.
[4] J. Spence. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes , 2013, Clinical chemistry and laboratory medicine.
[5] M. Wahlqvist,et al. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. , 2012, Clinical nutrition.
[6] Xiping Xu,et al. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. , 2012, Atherosclerosis.
[7] Y. Park,et al. Use of Serum Homocysteine to Predict Cardiovascular Disease in Korean Men with or without Metabolic Syndrome , 2012, Journal of Korean medical science.
[8] Arif Ali,et al. Lowering homocysteine and modifying nutritional status with folic acid and vitamin B12 in Indian patients of vascular disease , 2012, Journal of clinical biochemistry and nutrition.
[9] S. Öztürk,et al. Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and non-metabolic syndrome: case-control study , 2012, Turkish Journal of Medical Sciences.
[10] Chittaranjan S. Yajnik,et al. Marked gender difference in plasma total homocysteine concentrations in indian adults with low vitamin B₁₂. , 2011, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[11] A. Yadav,et al. Homocysteine, lipid indices and antioxidants in patients with ischaemic heart disease from Maharashtra, India. , 2009, Singapore medical journal.
[12] V. Rajadhyaksha,et al. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia:an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation)* , 2006, Current medical research and opinion.
[13] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[14] H. McNulty,et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease , 2002, The Lancet.
[15] D. Corella,et al. Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study. , 2011, Clinical hemorheology and microcirculation.
[16] A. Güven. PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH METABOLIC SYNDROME , 2004 .